The Application of Spasmolytic in PCLE Examination of Superior Gastrointestinal Endoscope

NCT02811341 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2016-06-23

No results posted yet for this study

Summary

Scopolamine butylbromide might be helpful for the outcome of superior gastrointestinal endoscope examination.

Conditions

  • Using Copolamine Butylbromide in Probe-based Confocal Laser Endomicroscopy for Gastroendoscopy Examination

Interventions

DRUG

Scopolamine Hydrobromide

DRUG

normal saline

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Yanqing Li, MD.PhD. · Qilu Hospital, Shandong University

  • Yanqing Li, PhD. MD. · Department of Gastroenterology, Qilu Hospital, Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-02-28
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02811341 on ClinicalTrials.gov